Home β€Ί Stock analysis β€Ί ISPC

iSpecimen (ISPC) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

ISPC slides 11.0% to $0.92, a 52-week low. Closed at $0.92, -10.97% vs the prior close of $1.03. Day range $0.91–$1.02, opened at $1.02.

Last close$0.92-10.97%
Day range0.91–1.02
Open1.02
Volume46.37K
52-week range0.91–36.32
Avg volume (20d)349.58K

ISPC daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” ISPC slides 11.0% to $0.92, a 52-week low
Oct 15, 2026 β€” ISPC rises 1.0% to $1.03
Oct 14, 2026 β€” ISPC slides 5.6% to $1.02, a 52-week low, 3 down days in a row
Oct 13, 2026 β€” ISPC ends flat (+0.0%) to $1.08
Oct 12, 2026 β€” ISPC slides 4.4% to $1.08
Oct 9, 2026 β€” ISPC jumps 3.7% to $1.13
Oct 8, 2026 β€” ISPC dips 0.9% to $1.09
Oct 7, 2026 β€” ISPC rises 2.8% to $1.10
Oct 6, 2026 β€” ISPC rises 1.9% to $1.07
Oct 5, 2026 β€” ISPC dips 2.8% to $1.05, a 52-week low, 4 down days in a row
Oct 2, 2026 β€” ISPC slides 5.3% to $1.08, a 52-week low, 3 down days in a row

ISPC latest news & SEC filings

Every SEC filing by or about ISPC in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 9, 2026 Β· Form PRER14A β€” PRER14A filing

PRER14A filing

Source: SEC EDGAR filing 0001213900-26-108577

Oct 9, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001213900-26-108501

Sep 14, 2026 Β· Form DEF 14A β€” Proxy statement

Proxy statement β€” agenda for the shareholder meeting (board elections, executive pay, votes)

Source: SEC EDGAR filing 0001213900-26-099770

Sep 10, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001213900-26-098847

Sep 4, 2026 Β· Form PRE 14A β€” Preliminary proxy statement

Preliminary proxy statement

Source: SEC EDGAR filing 0001213900-26-097765

Sep 4, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001213900-26-097726

Aug 31, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001213900-26-095801

Aug 14, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001213900-26-090273

Aug 14, 2026 Β· Form 10-Q β€” Quarterly report

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 30, 2026:

Source: SEC EDGAR filing 0001213900-26-090226

Aug 11, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001213900-26-087877

Aug 7, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001213900-26-086768

Aug 7, 2026 Β· Form 424B4 β€” Final prospectus with offering price

Final prospectus with offering price

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001213900-26-086434

Jul 30, 2026 Β· Form EFFECT β€” EFFECT filing

EFFECT filing

Source: SEC EDGAR filing 9999999995-26-002496

Jul 17, 2026 Β· Form S-1/A β€” S-1/A filing

S-1/A filing

An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.

Source: SEC EDGAR filing 0001213900-26-078869

Jul 14, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001213900-26-077998

Things to know before you trade ISPC

ISPC market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20261.021.020.910.9246.37K
Oct 15, 20260.981.050.971.03100.00K
Oct 14, 20261.071.071.021.0265.70K
Oct 13, 20261.071.101.031.0869.20K
Oct 12, 20261.121.131.051.0844.90K
Oct 9, 20261.101.151.101.1371.10K
Oct 8, 20261.091.131.071.0970.80K
Oct 7, 20261.071.111.051.1051.40K
Oct 6, 20261.041.101.031.07101.00K
Oct 5, 20261.081.091.021.05124.80K
Oct 2, 20261.151.151.041.08147.60K
Oct 1, 20261.171.191.141.1425.70K
Sep 30, 20261.201.241.181.1859.90K
Sep 29, 20261.201.251.151.23125.90K
Sep 28, 20261.211.331.171.21444.20K
Sep 25, 20261.301.301.181.26534.00K
Sep 24, 20261.241.281.221.254.58M
Sep 23, 20261.291.291.211.2193.10K
Sep 22, 20261.311.321.251.25104.90K
Sep 21, 20261.361.381.321.32135.50K

About iSpecimen

iSpecimen (ISPC) is listed on the Nasdaq and classified by the SEC under β€œServices-Commercial Physical & Biological Research”. Its business address is in WOBURN, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1558569.

ISPC board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Arphing LeeDirectorNov 19, 2025

Executive officers

NameTitleLatest filing
No Form 3/4/5 filings by this group in the last 12 months.

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

ISPC financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025β€”$-10.49M-2.28$-4.24M
Dec 31, 2024β€”$-12.50M-17.58$-8.26M
Dec 31, 2023$9.93M$-11.10M-24.55$-5.81M
Dec 31, 2022$10.40M$-10.25M-1.16$-5.82M
Dec 31, 2021$11.14M$-8.96M-2.09$-10.67M

Latest balance sheet: total assets $7.39M, total liabilities $5.66M, cash $4.41M (as of Jun 30, 2026).

ISPC earnings / results-day log

DateFilingClose that day
Aug 6, 20248-K Item 2.02 (results)β€”
May 7, 20248-K Item 2.02 (results)β€”
Mar 14, 20248-K Item 2.02 (results)β€”
Nov 2, 20238-K Item 2.02 (results)β€”
Oct 23, 20238-K Item 2.02 (results)β€”
Aug 2, 20238-K Item 2.02 (results)β€”
May 4, 20238-K Item 2.02 (results)β€”
Mar 14, 20238-K Item 2.02 (results)β€”
Nov 8, 20228-K Item 2.02 (results)β€”
Aug 4, 20228-K Item 2.02 (results)β€”
May 10, 20228-K Item 2.02 (results)β€”
Feb 17, 20228-K Item 2.02 (results)β€”

Related stocks Β· Services-Commercial Physical & Biological Research

Iqvia (IQV)Charles River Laboratories International (CRL)Incyte (INCY)Icon (ICLR)Medpace (MEDP)Absci (ABSI)bioAffinity Technologies (BIAF)OmniAb (OABI)Nrc Health (NRC)Maxcyte (MXCT)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on ISPC

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.